GB8316415D0 - Azetidinone intermediates - Google Patents

Azetidinone intermediates

Info

Publication number
GB8316415D0
GB8316415D0 GB838316415A GB8316415A GB8316415D0 GB 8316415 D0 GB8316415 D0 GB 8316415D0 GB 838316415 A GB838316415 A GB 838316415A GB 8316415 A GB8316415 A GB 8316415A GB 8316415 D0 GB8316415 D0 GB 8316415D0
Authority
GB
United Kingdom
Prior art keywords
azetidinone intermediates
azetidinone
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB838316415A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Priority to GB838316415A priority Critical patent/GB8316415D0/en
Publication of GB8316415D0 publication Critical patent/GB8316415D0/en
Priority to DE19843421722 priority patent/DE3421722A1/en
Priority to BE0/213120A priority patent/BE899892A/en
Priority to JP59120883A priority patent/JPS6011463A/en
Priority to GB08415514A priority patent/GB2142019B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB838316415A 1983-06-16 1983-06-16 Azetidinone intermediates Pending GB8316415D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB838316415A GB8316415D0 (en) 1983-06-16 1983-06-16 Azetidinone intermediates
DE19843421722 DE3421722A1 (en) 1983-06-16 1984-06-12 Novel azetidinone intermediates and their use in the synthesis of 2-(substituted methyl)-penem-3-carboxylates
BE0/213120A BE899892A (en) 1983-06-16 1984-06-13 NEW INTERMEDIATE PRODUCTS OF AZETIDINONE, AS WELL AS THEIR USE IN THE SYNTHESIS OF 2- (METHYL SUBSTITUE) PENEM-3-CARBOXYLATES.
JP59120883A JPS6011463A (en) 1983-06-16 1984-06-14 Novel azetidinone compound
GB08415514A GB2142019B (en) 1983-06-16 1984-06-18 Novel azetidinone intermediates and their use in the synthesis of 2-(substituted methyl) penem-3-carboxylates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838316415A GB8316415D0 (en) 1983-06-16 1983-06-16 Azetidinone intermediates

Publications (1)

Publication Number Publication Date
GB8316415D0 true GB8316415D0 (en) 1983-07-20

Family

ID=10544319

Family Applications (1)

Application Number Title Priority Date Filing Date
GB838316415A Pending GB8316415D0 (en) 1983-06-16 1983-06-16 Azetidinone intermediates

Country Status (4)

Country Link
JP (1) JPS6011463A (en)
BE (1) BE899892A (en)
DE (1) DE3421722A1 (en)
GB (1) GB8316415D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10087190B1 (en) * 2017-04-24 2018-10-02 Purdue Research Foundation Lactones

Also Published As

Publication number Publication date
BE899892A (en) 1984-10-01
JPS6011463A (en) 1985-01-21
DE3421722A1 (en) 1984-12-20

Similar Documents

Publication Publication Date Title
GB8610790D0 (en) Intermediates
GB2190914B (en) Intermediates for carboxybutenamidocephalosporins
GB8420236D0 (en) Penems
GB2144419B (en) Azetidinones
GB8626464D0 (en) Intermediates
ZA847779B (en) Novel pipelock
GB2159818B (en) Carbapenem intermediates
GB8423456D0 (en) Azetidinones
IL70782A (en) N-dicarboxymethyl azetidin-2-ones
GB8432809D0 (en) Diamino-thiadiazole intermediates
GB2146025B (en) Novel phenoxyalkylphosphinates and -phosphonates
DE3472556D1 (en) Novel aroylimidazolones
GB2133403B (en) Azetidinone derivatives
GB8415514D0 (en) Azetidinone intermediates
GB8316415D0 (en) Azetidinone intermediates
GB2136009B (en) Carbapenem intermediates
GB2171697B (en) 7-amino-cephem intermediates
GB8702275D0 (en) Intermediates for 1 2 4-triazolones
ZA854659B (en) Substituted azetidinone compounds
GB8301702D0 (en) Azetidine compounds
JPS57159760A (en) Azetidinone compound
ZA847068B (en) Azetidinones
GB8516680D0 (en) Intermediates
GB2113215B (en) Azetidinones
GB2197865B (en) Azetidinone derivatives